Oman Pharmaceuticals and Healthcare Report Q1 2015

  • December 2014
  • -
  • Business Monitor International
  • -
  • 101 pages

BMI View:

The Omani government is placing an increasing emphasis on the healthcare sector, demonstrated by a large increase in funding for the 2015 national budget. Much of this investment is allocated to building state-of-the-art healthcare infrastructure in an attempt to promote the medical tourism industry. We highlight continuing commercial opportunities in the Omani pharmaceutical market for multinational drugmakers due to the high penetration of patented medicines, lack of local competition and the development of the private healthcare sector.

Headline Expenditure Projections

- Pharmaceuticals: OMR187mn (USD487mn) in 2013 to OMR200mn (USD518mn) in 2014; 6.6% in local currency and US dollar terms. Forecast broadly in line with Q414.
- Healthcare: OMR831mn (USD2.16bn) in 2013 to OMR891mn (USD2.31bn) in 2014; +7.2% in local currency and US dollar terms. Forecast unchanged from Q414.

Table Of Contents

Oman Pharmaceuticals and Healthcare Report Q1 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Industry Forecast 13
Pharmaceutical Market Forecast 13
Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2010-2018) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2010-2018) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2010-2018) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2010-2018) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2010-2018) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2010-2018) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2010-2018) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2010-2018) 24
Pharmaceutical Trade Forecast 25
Table: Pharmaceutical Trade Data And Forecasts (Oman 2012-2018) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Oman 2012-2018) 26
Other Healthcare Data 27
Key Risks To BMI's Forecast Scenario 28
Macroeconomic Forecasts 30
Economic Analysis 30
Table: GCC - REAL GDP GROWTH, % CHG Y-O-Y 34
Industry Risk Reward Indicies 37
Middle East and Africa Risk/Reward Index 37
Oman Risk/Reward Index 44
Rewards 44
Risks 45
Market Overview 46
Industry Trends And Developments 47
Industry Trends And Developments 47
Epidemiology 47
Communicable Diseases 47
Non-Communicable Diseases 48
Healthcare Sector 49
Public Healthcare Sector Developments 52
Private Healthcare Sector Developments 54
Table: Number Of Health Centres In Oman By Region 57
Table: Number And Type Of Health Institutions In Oman In 2012 57
Healthcare Insurance 58
Telemedicine 59
Medical Tourism 60
Research And Development 62
Clinical Trials 63
Table: Clinical Trials In Oman 64
Regulatory Development 65
Regulatory Developments 66
Intellectual Property Regime 66
Regional Harmonisation 67
Pricing And Reimbursement Regime 68
Competitive Landscape 72
Domestic Pharmaceutical Industry 72
Foreign Pharmaceutical Industry 73
Pharmaceutical Distribution 74
Company Profile 75
Zynova/Oman Pharmaceutical Products Company 75
National Pharmaceutical Industries (NPI) 78
Novartis 81
GlaxoSmithKline 84
Sanofi 86
Johnson and Johnson 88
Demographic Forecast 90
Table: Population Headline Indicators (Oman 1990-2025) 91
Table: Key Population Ratios (Oman 1990-2025) 91
Table: Urban/Rural Population and Life Expectancy (Oman 1990-2025) 92
Table: Population By Age Group (Oman 1990-2025) 92
Table: Population By Age Group % (Oman 1990-2025) 93
Glossary 95
Methodology 97
Pharmaceutical Expenditure Forecast Model 97
Healthcare Expenditure Forecast Model 97
Notes On Methodology 98
Risk/Reward Index Methodology 99
Index Overview 100
Table: Pharmaceutical Risk/Reward Index Indicators 100
Indicator Weightings 101

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with ...

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered ...

Opportunity in the Indian Pharmaceutical Packaging Market - 2015 ; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

Opportunity in the Indian Pharmaceutical Packaging Market - 2015 ; Market size, Market share, Market landscape, Market trend analysis, Growth drivers, Future opportunity, Future forecast

  • $ 6 000
  • Industry report
  • January 2015
  • by Feedback Business Consulting

This report provides an insight into the Opportunity in the Indian Pharmaceutical Packaging current market scenario, structure and practices. In depth market scenario includes; - All India pharmaceutical ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.